Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
來自Calliditas Therapeutics分析師評級的關鍵見解：你需要知道的
In the last three months, 5 analysts have published ratings on Calliditas Therapeutics (NASDAQ:CALT), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師對calliditas therapeutics（納斯達克股票代碼：CALT）發佈了評級，提供了從看好到看淡的多樣化觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $40.4, along with a high estimate of $45.00 and a low estimate of $39.00. Highlighting a 25.64% decrease, the current average has fallen from the previous average price target of $54.33.
分析師提供了更深入的見解，建立了12個月的價格目標，顯示平均目標爲40.4美元，最高估價爲45.00美元，最低估價爲39.00美元。當前的平均價格已下跌了25.64％，從先前的平均價格目標54.33美元下降。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
A clear picture of...
通過對最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。